Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart

Current Cardiology Reviews

Volumn 6, Issue 4, 2010, Pages 255-264

  Müller, Alison L ^a   Dhalla, Naranjan S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardioprotection; Ischemia reperfusion injury; Ischemic preconditioning; Oxidative stress; Reactive oxygen species; Subcellular organelles

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DAMAGE; CELL NUCLEUS; CELL ORGANELLE; GLYCOCALYX; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HYPEROXIA; ISCHEMIC PRECONDITIONING; MYOFILAMENT; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SARCOLEMMA; SARCOPLASMIC RETICULUM;

EID: 78651342552     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310793566118     Document Type: Article

References (131)

1. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress incardiovascular diseases. J Hypertens 2000; 18(6): 655-73.
2. Ytrehus K, Myklebust R, Olsen R, Mjos OD. Ultrastructuralchanges induced in the isolated rat heart by enzymaticallygenerated oxygen radicals. J Mol Cell Cardiol 1987; 19(4): 379-89.
3. Dhalla NS, Golfman L, Takeda S, et al. Evidence for the role ofoxidative stress in acute ischemic heart disease: a brief review. CanJ Cardiol 1999; 15(5): 587-93.
4. Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: aradical view - Free radicals in pre and postconditioning. BiochimBiophys Acta 2009; 1787(7): 781-93.
5. Zorov DB, Filburn CR, Klotz LO, et al. Reactive oxygen species(ROS)-induced ROS release: a new phenomenon accompanyinginduction of the mitochondrial permeability transition in cardiacmyocytes. J Exp Med 2000; 192(7): 1001-14.
6. Das S, Khan N, Mukherjee S, et al. Redox regulation ofresveratrol-mediated switching of death signal into survival signal. Free Radic Biol Med 2008; 44(1): 82-90.
7. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during briefhypoxia induce preconditioning in cardiomyocytes. J Biol Chem 1998; 273(29): 18092-8.
8. Angelos MG, Kutala VK, Torres CA, et al. Hypoxic reperfusion ofthe ischemic heart and oxygen radical generation. Am J PhysiolHeart Circ Physiol 2006; 290(1): H341-7.
9. Arora RC, Hess ML. Effect of reduced oxygen intermediates onsarcolemmal muscarinic receptors from canine heart. BiochemBiophys Res Commun 1985; 130(1): 133-40.
10. Murphy E, Steenbergen C. Mechanisms underlying acuteprotection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88(2): 581-609.
11. Murry CE, Jennings RB, Reimer KA. Preconditioning withischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74(5): 1124-36.
12. Saini HK, Machackova J, Dhalla NS. Role of reactive oxygenspecies in ischemic preconditioning of subcellular organelles in theheart. Antioxid Redox Signal 2004; 6(2): 393-404.
13. Morihira M, Hasebe N, Baljinnyam E, et al. Ischemicpreconditioning enhances scavenging activity of reactive oxygenspecies and diminishes transmural difference of infarct size. Am JPhysiol Heart Circ Physiol 2006; 290(2): H577-83.
14. Meldrum DR, Cleveland JC, Jr., Moore EE, et al. Adaptive andmaladaptive mechanisms of cellular priming. Ann Surg 1997; 226(5): 587-98.
15. Zaugg M, Schaub MC. Signaling and cellular mechanisms incardiac protection by ischemic and pharmacological preconditioning. J Muscle Res Cell Motil 2003; 24(2-3): 219-49.
16. Przyklenk K, Kloner RA. Ischemic preconditioning: exploring theparadox. Prog Cardiovasc Dis 1998; 40(6): 517-47.
17. Das DK, Maulik N. Cardiac genomic response followingpreconditioning stimulus. Cardiovasc Res 2006; 70(2): 254-63.
18. Das DK, Engelman RM, Kimura Y. Molecular adaptation ofcellular defences following preconditioning of the heart by repeatedischaemia. Cardiovasc Res 1993; 27(4): 578-84.
19. Morgan EN, Boyle EM, Jr., Yun W, et al. An essential role for NFkappaBin the cardioadaptive response to ischemia. Ann ThoracSurg 1999; 68(2): 377-82.
20. Shinmura K, Xuan YT, Tang XL, et al. Inducible nitric oxidesynthase modulates cyclooxygenase-2 activity in the heart ofconscious rabbits during the late phase of ischemicpreconditioning. Circ Res 2002; 90(5): 602-8.
21. Hoshida S, Yamashita N, Otsu K, Hori M. The importance ofmanganese superoxide dismutase in delayed preconditioning:involvement of reactive oxygen species and cytokines. CardiovascRes 2002; 55(3): 495-505.
22. Maulik N, Engelman RM, Rousou JA, et al. Ischemicpreconditioning reduces apoptosis by upregulating anti-death geneBcl-2. Circulation 1999; 100(19): II369-75.
23. Townsend PA, Cutress RI, Carroll CJ, et al. BAG-1 proteinsprotect cardiac myocytes from simulated ischemia/reperfusioninducedapoptosis via an alternate mechanism of cell survivalindependent of the proteasome. J Biol Chem 2004; 279(20): 20723-8.
24. Maulik N, Das DK. Molecular cloning, sequencing and expressionanalysis of a fatty acid transport gene in rat heart induced byischemic preconditioning and oxidative stress. Mol Cell Biochem 1996; 160-161: 241-7.
25. Simkhovich BZ, Marjoram P, Poizat C, et al. Brief episode ofischemia activates protective genetic program in rat heart: a genechip study. Cardiovasc Res 2003; 59(2): 450-9.
26. Beresewicz A, Czarnowska E, Maczewski M. Ischemicpreconditioning and superoxide dismutase protect againstendothelial dysfunction and endothelium glycocalyx disruption inthe postischemic guinea-pig hearts. Mol Cell Biochem 1998; 186(1-2): 87-97.
27. Lalu MM, Csonka C, Giricz Z, et al. Preconditioning decreasesischemia/reperfusion-induced release and activation of matrixmetalloproteinase-2. Biochem Biophys Res Commun 2002; 296(4): 937-41.
28. Cheung PY, Sawicki G, Wozniak M, et al. Matrixmetalloproteinase-2 contributes to ischemia-reperfusion injury inthe heart. Circulation 2000; 101(15): 1833-9.
29. Rodrigo R, Castillo R, Cereceda M, Asenjo R, Zamorano J, Araya J. Non-hypoxic preconditioning of myocardium againstpostoperative atrial fibrillation: mechanism based on enhancementof the antioxidant defense system. Med Hypotheses 2007; 69(6): 1242-8.
30. Guay J, Lambert H, Gingras-Breton G, et al. Regulation of actinfilament dynamics by p38 map kinase-mediated phosphorylation ofheat shock protein 27. J Cell Sci 1997; 110 (3): 357-68.
31. Landry J, Huot J. Modulation of actin dynamics during stress andphysiological stimulation by a signaling pathway involving p38MAP kinase and heat-shock protein 27. Biochem Cell Biol 1995; 73(9-10): 703-7.
32. Das DK, Maulik N, Sato M, Ray PS. Reactive oxygen speciesfunction as second messenger during ischemic preconditioning ofheart. Mol Cell Biochem 1999; 196(1-2): 59-67.
33. Nakamura T, Hayashi H, Satoh H, et al. A single cell model ofmyocardial reperfusion injury: changes in intracellular Na+ andCa2+ concentrations in guinea pig ventricular myocytes. Mol CellBiochem 1999; 194(1-2): 147-57.
34. Nayler WG. The role of calcium in the ischemic myocardium. AmJ Pathol 1981; 102(2): 262-70.
35. Nayler WG, Panagiotopoulos S, Elz JS, Daly MJ. Calciummediateddamage during post-ischaemic reperfusion. J Mol CellCardiol 1988; 20(2): 41-54.
36. Temsah RM, Netticadan T, Chapman D, et al. Alterations insarcoplasmic reticulum function and gene expression in ischemicreperfusedrat heart. Am J Physiol 1999; 277(2): H584-94.
37. Osada M, Netticadan T, Tamura K, Dhalla NS. Modification ofischemia-reperfusion-induced changes in cardiac sarcoplasmicreticulum by preconditioning. Am J Physiol 1998; 274(2): H2025-34.
38. Temsah RM, Kawabata K, Chapman D, Dhalla NS. Preconditioning prevents alterations in cardiac SR gene expressiondue to ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2002; 282(4): H1461-6.
39. 2+ exchanger contributes tosarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. FreeRadic Biol Med 2010; 48(9): 1182-7.
40. Kaplan P, Babusikova E, Lehotsky J, Dobrota D. Free radicalinducedprotein modification and inhibition of Ca2+-ATPase ofcardiac sarcoplasmic reticulum. Mol Cell Biochem 2003; 248(1-2): 41-7.
41. Zucchi R, Yu G, Galbani P, et al. Sulfhydryl redox state affectssusceptibility to ischemia and sarcoplasmic reticulum Ca2+ releasein rat heart. Implications for ischemic preconditioning. Circ Res 1998; 83(9): 908-15.
42. Musat S, Dhalla NS. Alteration in cardiac sarcolemmal ATPreceptors by oxyradicals. Ann N Y Acad Sci 1996; 793: 1-12.
43. Shao Q, Matsubara T, Bhatt SK, Dhalla NS. Inhibition of cardiacsarcolemma Na+-K+ ATPase by oxyradical generating systems. Mol Cell Biochem 1995; 147(1-2): 139-44.
44. Vinnikova AK, Kukreja RC, Hess ML. Singlet oxygen-inducedinhibition of cardiac sarcolemmal Na+/K+-ATPase. J Mol CellCardiol 1992; 24(5): 465-70.
45. Fuller W, Parmar V, Eaton P, et al. Cardiac ischemia causesinhibition of the Na/K ATPase by a labile cytosolic compoundwhose production is linked to oxidant stress. Cardiovasc Res 2003; 57(4): 1044-51.
46. Elmoselhi AB, Butcher A, Samson SE, Grover AK. Free radicalsuncouple the sodium pump in pig coronary artery. Am J Physiol 1994; 266(1): C720-8.
47. Meij JT, Suzuki S, Panagia V, Dhalla NS. Oxidative stressmodifies the activity of cardiac sarcolemmal phospholipase C. Biochim Biophys Acta 1994; 1199(1): 6-12.
48. Dai J, Meij JT, Padua R, Panagia V. Depression of cardiacsarcolemmal phospholipase D activity by oxidant-induced thiolmodification. Circ Res 1992; 71(4): 970-7.
49. Mesaeli N, Tappia PS, Suzuki S, et al. Oxidants depress thesynthesis of phosphatidylinositol 4,5-bisphosphate in heartsarcolemma. Arch Biochem Biophys 2000; 382(1): 48-56.
50. Slezak J, Tribulova N, Pristacova J, et al. Hydrogen peroxidechanges in ischemic and reperfused heart. Cytochemistry andbiochemical and X-ray microanalysis. Am J Pathol 1995; 147(3): 772-81.
51. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassiumchannels prevents myocardial preconditioning in dogs. Circ Res 1992; 70(2): 223-33.
52. Tokube K, Kiyosue T, Arita M. Openings of cardiac KATPchannel by oxygen free radicals produced by xanthine oxidasereaction. Am J Physiol 1996; 271(2): H478-89.
53. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATPsensitiveK+ channels and myocardial preconditioning. Circ Res 1999; 84(9): 973-9.
54. Jovanovic A, Jovanovic S, Lorenz E, Terzic A. Recombinantcardiac ATP-sensitive K+ channel subunits confer resistance tochemical hypoxia-reoxygenation injury. Circulation 1998; 98(15): 1548-55.
55. Marinovic J, Bosnjak ZJ, Stadnicka A. Distinct roles forsarcolemmal and mitochondrial adenosine triphosphate-sensitivepotassium channels in isoflurane-induced protection againstoxidative stress. Anesthesiology 2006; 105(1): 98-104.
56. Gumina RJ, Pucar D, Bast P, et al. Knockout of Kir6. 2 negatesischemic preconditioning-induced protection of myocardialenergetics. Am J Physiol Heart Circ Physiol 2003; 284(6): H2106-13.
57. Marinovic J, Ljubkovic M, Stadnicka A, et al. Role of sarcolemmalATP-sensitive potassium channel in oxidative stress-inducedapoptosis: mitochondrial connection. Am J Physiol Heart CircPhysiol 2008; 294(3): H1317-25.
58. Matejikova J, Kucharska J, Pinterova M, et al. Protection againstischemia-induced ventricular arrhythmias and myocardialdysfunction conferred by preconditioning in the rat heart:involvement of mitochondrial K(ATP) channels and reactiveoxygen species. Physiol Res 2009; 58(1): 9-19.
59. Forbes RA, Steenbergen C, Murphy E. Diazoxide-inducedcardioprotection requires signaling through a redox-sensitivemechanism. Circ Res 2001; 88(8): 802-9.
60. Das B, Sarkar C. Similarities between ischemic preconditioningand 17 beta-estradiol mediated cardiomyocyte KATP channelactivation leading to cardioprotective and antiarrhythmic effectsduring ischemia/reperfusion in the intact rabbit heart. J CardiovascPharmacol 2006; 47(2): 277-86.
61. Facundo HT, de Paula JG, Kowaltowski AJ. Mitochondrial ATPsensitiveK+ channels are redox-sensitive pathways that controlreactive oxygen species production. Free Radic Biol Med 2007; 42(7): 1039-48.
62. Fryer RM, Eells JT, Hsu AK, et al. Ischemic preconditioning inrats: role of mitochondrial K(ATP) channel in preservation ofmitochondrial function. Am J Physiol Heart Circ Physiol 2000; 278(1): H305-12.
63. Burwell LS, Nadtochiy SM, Brookes PS. Cardioprotection bymetabolic shut-down and gradual wake-up. J Mol Cell Cardiol 2009; 46(6): 804-10.
64. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substratemetabolism in the normal and failing heart. Physiol Rev 2005; 85(3): 1093-129.
65. Kussmaul L, Hirst J. The mechanism of superoxide production byNADH:ubiquinone oxidoreductase (complex I) from bovine heartmitochondria. Proc Natl Acad Sci U S A 2006; 103(20): 7607-12.
66. Fontaine E, Bernardi P. Progress on the mitochondrial permeabilitytransition pore: regulation by complex I and ubiquinone analogs. JBioenerg Biomembr 1999; 31(4): 335-45.
67. Burwell LS, Nadtochiy SM, Tompkins AJ, et al. Direct evidencefor S-nitrosation of mitochondrial complex I. Biochem J 2006; 394(3): 627-34.
68. Brookes PS, Shiva S, Patel RP, Darley-Usmar VM. Measurementof mitochondrial respiratory thresholds and the control ofrespiration by nitric oxide. Methods Enzymol 2002; 359: 305-19.
69. Wojtovich AP, Brookes PS. The endogenous mitochondrialcomplex II inhibitor malonate regulates mitochondrial ATPsensitivepotassium channels: implications for ischemicpreconditioning. Biochim Biophys Acta 2008; 1777(7-8): 882-9.
70. Brunori M, Forte E, Arese M, et al. Nitric oxide and the respiratoryenzyme. Biochim Biophys Acta 2006; 1757(9-10): 1144-54.
71. Nadtochiy SM, Baker PR, Freeman BA, Brookes PS. Mitochondrial nitroalkene formation and mild uncoupling inischaemic preconditioning: implications for cardioprotection. Cardiovasc Res 2009; 82(2): 333-40.
72. Batthyany C, Schopfer FJ, Baker PR, et al. Reversible posttranslationalmodification of proteins by nitrated fatty acids in vivo. J Biol Chem 2006; 281(29): 20450-63.
73. Yabe K, Nasa Y, Sato M, et al. Preconditioning preservesmitochondrial function and glycolytic flux during an early periodof reperfusion in perfused rat hearts. Cardiovasc Res 1997; 33(3): 677-85.
74. Zuurbier CJ, Eerbeek O, Meijer AJ. Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution. Am JPhysiol Heart Circ Physiol 2005; 289(1): H496-9.
75. Sun L, Shukair S, Naik TJ, et al. Glucose phosphorylation andmitochondrial binding are required for the protective effects ofhexokinases I and II. Mol Cell Biol 2008; 28(3): 1007-17.
76. Kwak HJ, Park KM, Choi HE, Park HY. Protective mechanisms ofNO preconditioning against NO-induced apoptosis in H9c2 cells:role of PKC and COX-2. Free Radic Res 2009; 43(8): 744-52.
77. Bolli R, Shinmura K, Tang XL, et al. Discovery of a new functionof cyclooxygenase (COX)-2: COX-2 is a cardioprotective proteinthat alleviates ischemia/reperfusion injury and mediates the latephase of preconditioning. Cardiovasc Res 2002; 55(3): 506-19.
78. Shinmura K, Tang XL, Wang Y, et al. Cyclooxygenase-2 mediatesthe cardioprotective effects of the late phase of ischemicpreconditioning in conscious rabbits. Proc Natl Acad Sci U S A 2000; 97(18): 10197-202.
79. Farber NE, Pieper GM, Thomas JP, Gross GJ. Beneficial effects ofiloprost in the stunned canine myocardium. Circ Res 1988; 62(2): 204-15.
80. Hide EJ, Thiemermann C. Sulprostone-induced reduction ofmyocardial infarct size in the rabbit by activation of ATP-sensitivepotassium channels. Br J Pharmacol 1996; 118(6): 1409-14.
81. Baines CP, Goto M, Downey JM. Oxygen radicals released duringischemic preconditioning contribute to cardioprotection in therabbit myocardium. J Mol Cell Cardiol 1997; 29(1): 207-16.
82. Ping P, Takano H, Zhang J, et al. Isoform-selective activation ofprotein kinase C by nitric oxide in the heart of conscious rabbits: asignaling mechanism for both nitric oxide-induced and ischemiainducedpreconditioning. Circ Res 1999; 84(5): 587-604.
83. Teng JC, Kay H, Chen Q, et al. Mechanisms related to thecardioprotective effects of protein kinase C epsilon (PKC epsilon)peptide activator or inhibitor in rat ischemia/reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol 2008; 378(1): 1-15.
84. Malhotra A, Kang BP, Hashmi S, Meggs LG. PKCepsilon inhibitsthe hyperglycemia-induced apoptosis signal in adult rat ventricularmyocytes. Mol Cell Biochem 2005; 268(1-2): 169-73.
85. Tappia PS, Dent MR, Dhalla NS. Oxidative stress and redoxregulation of phospholipase D in myocardial disease. Free RadicBiol Med 2006; 41(3): 349-61.
86. Asemu G, Dent MR, Singal T, et al. Differential changes inphospholipase D and phosphatidate phosphohydrolase activities inischemia-reperfusion of rat heart. Arch Biochem Biophys 2005; 436(1): 136-44.
87. Raeburn CD, Zimmerman MA, Arya J, et al. Ischemicpreconditioning: fact or fantasy? J Card Surg 2002; 17(6): 536-42.
88. Arner ES, Holmgren A. Physiological functions of thioredoxin andthioredoxin reductase. Eur J Biochem 2000; 267(20): 6102-9.
89. Prieto-Alamo MJ, Jurado J, Gallardo-Madueno R, et al. Transcriptional regulation of glutaredoxin and thioredoxinpathways and related enzymes in response to oxidative stress. JBiol Chem 2000; 275(18): 13398-405.
90. Turoczi T, Chang VW, Engelman RM, et al. Thioredoxin redoxsignaling in the ischemic heart: an insight with transgenic miceoverexpressing Trx1. J Mol Cell Cardiol 2003; 35(6): 695-704.
91. Das DK, Maulik N. Preconditioning potentiates redox signalingand converts death signal into survival signal. Arch BiochemBiophys 2003; 420(2): 305-11.
92. van Deel ED, Lu Z, Xu X, et al. Extracellular superoxide dismutaseprotects the heart against oxidative stress and hypertrophy aftermyocardial infarction. Free Radic Biol Med 2008; 44(7): 1305-13.
93. Yamashita N, Hoshida S, Taniguchi N, et al. A "second window ofprotection" occurs 24 h after ischemic preconditioning in the ratheart. J Mol Cell Cardiol 1998; 30(6): 1181-9.
94. Maczewski M, Duda M, Pawlak W, Beresewicz A. Endothelialprotection from reperfusion injury by ischemic preconditioning anddiazoxide involves a SOD-like anti-O2- mechanism. J PhysiolPharmacol 2004; 55(3): 537-50.
95. McLeod CJ, Aziz A, Hoyt RF, Jr., et al. Uncoupling proteins 2 and3 function in concert to augment tolerance to cardiac ischemia. JBiol Chem 2005; 280(39): 33470-6.
96. Krauss S, Zhang CY, Scorrano L, et al. Superoxide-mediatedactivation of uncoupling protein 2 causes pancreatic beta celldysfunction. J Clin Invest 2003; 112(12): 1831-42.
97. Krauss S, Zhang CY, Lowell BB. The mitochondrial uncouplingproteinhomologues. Nat Rev Mol Cell Biol 2005; 6(3): 248-61.
98. Turrens JF, Thornton J, Barnard ML, et al. Protection fromreperfusion injury by preconditioning hearts does not involveincreased antioxidant defenses. Am J Physiol 1992; 262(2): H585-9.
99. Eguchi M, Monden K, Miwa N. Role of MAPK phosphorylation incytoprotection by pro-vitamin C against oxidative stress-inducedinjuries in cultured cardiomyoblasts and perfused rat heart. J CellBiochem 2003; 90(2): 219-26.
100. Tsukaguchi H, Tokui T, Mackenzie B, et al. A family ofmammalian Na+-dependent L-ascorbic acid transporters. Nature 1999; 399(6731): 70-5.
101. Fujiwara M, Nagao N, Monden K, et al. Enhanced protectionagainst peroxidation-induced mortality of aortic endothelial cellsby ascorbic acid-2-O-phosphate abundantly accumulated in the cellas the dephosphorylated form. Free Radic Res 1997; 27(1): 97-104.
102. Arduini A, Mezzetti A, Porreca E, et al. Effect of ischemia andreperfusion on antioxidant enzymes and mitochondrial innermembrane proteins in perfused rat heart. Biochim Biophys Acta 1988; 970(2): 113-21.
103. Ferrari R, Ceconi C, Curello S, et al. Oxygen-mediated myocardialdamage during ischemia and reperfusion: role of the cellulardefenses against oxygen toxicity. J Mol Cell Cardiol 1985; 17: 937-45.
104. Porreca E, Del Boccio G, Lapenna D, et al. Myocardial antioxidantdefense mechanisms: time related changes after reperfusion of theischemic rat heart. Free Radic Res 1994; 20(3): 171-9.
105. Coudray C, Pucheu S, Boucher F, et al. Ischemia and reperfusioninjury in isolated rat heart: effect of reperfusion duration onxanthine oxidase, lipid peroxidation, and enzyme antioxidantsystems in myocardium. Basic Res Cardiol 1992; 87(5): 478-88.
106. Vanden Hoek T, Becker LB, Shao ZH, et al. Preconditioning incardiomyocytes protects by attenuating oxidant stress atreperfusion. Circ Res 2000; 86(5): 541-8.
107. Blasig IE, Ebert B, Hennig C, et al. Inverse relationship betweenESR spin trapping of oxyradicals and degree of functional recoveryduring myocardial reperfusion in isolated working rat heart. Cardiovasc Res 1990; 24(4): 263-70.
108. Costa VM, Silva R, Ferreira R, et al. Adrenaline in pro-oxidantconditions elicits intracellular survival pathways in isolated ratcardiomyocytes. Toxicology 2009; 257(1-2): 70-9.
109. Lee JW, Bobst EV, Wang YG, et al. Increased endogenousascorbyl free radical formation with singlet oxygen scavengers inreperfusion injury: an EPR and functional recovery study in rathearts. Cell Mol Biol (Noisy-le-grand) 2000; 46(8): 1383-95.
110. Ilangovan G, Zweier JL, Kuppusamy P. Mechanism of oxygeninducedEPR line broadening in lithium phthalocyaninemicrocrystals. J Magn Reson 2004; 170(1): 42-8.
111. Zhu X, Liu B, Zhou S, et al. Ischemic preconditioning prevents invivo hyperoxygenation in postischemic myocardium withpreservation of mitochondrial oxygen consumption. Am J PhysiolHeart Circ Physiol 2007; 293(3): H1442-50.
112. Zhao X, He G, Chen YR, et al. Endothelium-derived nitric oxideregulates postischemic myocardial oxygenation and oxygenconsumption by modulation of mitochondrial electron transport. Circulation 2005; 111(22): 2966-72.
113. Liu S, Liu W, Ding W, et al. Electron paramagnetic resonanceguidednormobaric hyperoxia treatment protects the brain bymaintaining penumbral oxygenation in a rat model of transientfocal cerebral ischemia. J Cereb Blood Flow Metab 2006; 26(10): 1274-84.
114. Singhal AB, Wang X, Sumii T, et al. Effects of normobarichyperoxia in a rat model of focal cerebral ischemia-reperfusion. JCereb Blood Flow Metab 2002; 22(7): 861-8.
115. Colantuono G, Tiravanti EA, Di Venosa N, et al. Hyperoxiaconfers myocardial protection in mechanically ventilated ratsthrough the generation of free radicals and opening ofmitochondrial ATP-sensitive potassium channels. Clin ExpPharmacol Physiol 2008; 35(1): 64-71.
116. Choi H, Kim SH, Chun YS, et al. In vivo hyperoxicpreconditioning prevents myocardial infarction by expressing bcl-2. Exp Biol Med (Maywood) 2006; 231(4): 463-72.
117. Sterling DL, Thornton JD, Swafford A, et al. Hyperbaric oxygenlimits infarct size in ischemic rabbit myocardium in vivo. Circulation 1993; 88(1): 1931-6.
118. Masini E, Salvemini D, Ndisang JF, et al. Cardioprotective activityof endogenous and exogenous nitric oxide on ischaemiareperfusion injury in isolated guinea pig hearts. Inflamm Res 1999; 48(11): 561-8.
119. Wink DA, Hanbauer I, Krishna MC, et al. Nitric oxide protectsagainst cellular damage and cytotoxicity from reactive oxygenspecies. Proc Natl Acad Sci U S A 1993; 90(21): 9813-7.
120. Rickover O, Zinman T, Kaplan D, Shainberg A. Exogenous nitricoxide triggers classic ischemic preconditioning by preventingintracellular Ca2+ overload in cardiomyocytes. Cell Calcium 2008; 43(4): 324-33.
121. Shiva S, Sack MN, Greer JJ, et al. Nitrite augments tolerance toischemia/reperfusion injury via the modulation of mitochondrialelectron transfer. J Exp Med 2007; 204(9): 2089-102.
122. Hill BG, Darley-Usmar VM. S-nitrosation and thiol switching inthe mitochondrion: a new paradigm for cardioprotection inischaemic preconditioning. Biochem J 2008; 412(2): e11-3.
123. Dahm CC, Moore K, Murphy MP. Persistent S-nitrosation ofcomplex I and other mitochondrial membrane proteins by Snitrosothiolsbut not nitric oxide or peroxynitrite: implications forthe interaction of nitric oxide with mitochondria. J Biol Chem 2006; 281(15): 10056-65.
124. Rossig L, Fichtlscherer B, Breitschopf K, et al. Nitric oxide inhibitscaspase-3 by S-nitrosation in vivo. J Biol Chem 1999; 274(11): 6823-6.
125. Cabigas BP, Su J, Hutchins W, et al. Hyperoxic and hyperbaricinducedcardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 2006; 72(1): 143-51.
126. Ii M, Nishimura H, Iwakura A, et al. Endothelial progenitor cellsare rapidly recruited to myocardium and mediate protective effectof ischemic preconditioning via "imported" nitric oxide synthaseactivity. Circulation 2005; 111(9): 1114-20.
127. Takahashi S, Mendelsohn ME. Synergistic activation of endothelialnitric-oxide synthase (eNOS) by HSP90 and Akt: calciumindependenteNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem 2003; 278(33): 30821-7.
128. Fontana J, Fulton D, Chen Y, et al. Domain mapping studies revealthat the M domain of hsp90 serves as a molecular scaffold toregulate Akt-dependent phosphorylation of endothelial nitric oxidesynthase and NO release. Circ Res 2002; 90(8): 866-73.
129. Venema RC, Venema VJ, Ju H, et al. Novel complexes ofguanylate cyclase with heat shock protein 90 and nitric oxidesynthase. Am J Physiol Heart Circ Physiol 2003; 285(2): H669-78.
130. Shi Y, Baker JE, Zhang C, et al. Chronic hypoxia increasesendothelial nitric oxide synthase generation of nitric oxide byincreasing heat shock protein 90 association and serinephosphorylation. Circ Res 2002; 91(4): 300-6.
131. Muscari C, Bonafe F, Gamberini C, et al. Early preconditioningprevents the loss of endothelial nitric oxide synthase and enhancesits activity in the ischemic/reperfused rat heart. Life Sci 2004; 74(9): 1127-37.